BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics Bpc 157 and TB 500 My protocol and results explained! I've talked about this with probably a dozen different guys over the last 4 months so hopefully this helps someone else. #progress # BPC 157: A Peptide with Remarkable Healing Potential Text2MD BPC 157: Miracle Healing Peptide or Hidden Danger?